Home › Therapeutic areas › Metabolic › Sanfilippo Syndrome

Sanfilippo Syndrome (1 companies)

Companies with an active program in Sanfilippo Syndrome.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
RARE Ultragenyx Pharmaceutical CardiovascularMetabolic+1 Rare 1 Approved $1.57B 10